These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 6400195

  • 1. Biodegradable polymers in controlled drug delivery.
    Heller J.
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [Abstract] [Full Text] [Related]

  • 2. Bioerodible polymers for ocular drug delivery.
    Deshpande AA, Heller J, Gurny R.
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
    Nam K, Watanabe J, Ishihara K.
    Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
    [Abstract] [Full Text] [Related]

  • 8. Biodegradable microsphere contraceptive system.
    Beck LR, Cowsar D.
    Acta Eur Fertil; 1980 Jun; 11(2):139-50. PubMed ID: 7211111
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H, Yoshihara K, Sawada T, Kondo H, Sako K.
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [Abstract] [Full Text] [Related]

  • 11. Modeling of swelling and drug release behavior of spontaneously forming hydrogels composed of phospholipid polymers.
    Nam K, Watanabe J, Ishihara K.
    Int J Pharm; 2004 May 04; 275(1-2):259-69. PubMed ID: 15081156
    [Abstract] [Full Text] [Related]

  • 12. Controlled release using a new bioerodible polyphosphazene matrix system.
    Laurencin CT, Koh HJ, Neenan TX, Allcock HR, Langer R.
    J Biomed Mater Res; 1987 Oct 04; 21(10):1231-46. PubMed ID: 3693386
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Materials and biological aspects of synthetic polymers in controlled drug release systems: problems and challenges.
    Bruck SD, Mueller EP.
    Crit Rev Ther Drug Carrier Syst; 1988 Oct 04; 5(3):171-87. PubMed ID: 3060266
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A review of parenteral sustained-release naltrexone systems.
    Olsen JL, Kincl FA.
    NIDA Res Monogr; 1981 Oct 04; 28():187-93. PubMed ID: 6791004
    [Abstract] [Full Text] [Related]

  • 20. Implantable controlled release systems.
    Langer R.
    Pharmacol Ther; 1983 Oct 04; 21(1):35-51. PubMed ID: 6353438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.